Brief: Orexo AB - Study Is Expected To Cost Sek 11 Million
25/10/2024 14:53
Oct 25 (Reuters) - Orexo AB ORX.ST :
* OREXO AB - STUDY IS EXPECTED TO COST SEK 11 MILLION
* OREXO - RESULTS FROM NEW OX640 STUDY EXPECTED TO BE
AVAILABLE
EARLY IN 2025
Source text for Eikon: ID:nPn4lcKW5a
Further company coverage: ORX.ST
((Reuters.Briefs@thomsonreuters.com))
Recent news on Orexo AB
See all newsBrief: Orexo Announces Positive Outcome From An In-Vivo Study Of Ox390
Brief: Orexo Announces Positive Outcome From An In-Vivo Study Of Ox390
Brief: Orexo Announces Positive Pre-Clinical Data For Nasal Atipamezole Using Amorphox Technology
Brief: Orexo AB Reports Q1 2026 Net Revenue Of Sek 5.0 Million
Sweden's Orexo Q1 revenue drops, net loss widens